Hsiao-Hsuan Kuo1,2,3, Mathias Lichterfeld1,2,3. 1. Infectious Disease Division, Brigham and Women's Hospital, Boston. 2. Ragon Institute of MGH, MIT and Harvard, Cambridge. 3. Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Reservoirs of HIV-1-infected cells persist long-term despite highly effective antiretroviral suppression therapy and represent the main barrier against a cure for HIV-1. This review summarizes recent advances in understanding the complexity and diversity of viral reservoir cells. RECENT FINDINGS: Latently infected memory CD4 T cells are the predominant cell compartment responsible for viral persistence, but some studies suggest that myeloid cells, and possibly hematopoietic progenitors, can also serve as long-term viral reservoirs. Specific phenotypic markers, including T-cell activation and exhaustion molecules, may denote CD4 T cells enriched for replication-competent proviruses. Clonal proliferation of infected CD4 T cells in vivo represents an important mechanism responsible for the remarkable long-term stability of the viral reservoir. Multiple new assays, including near full-genome proviral sequencing and simplified versions of viral outgrowth assays, are being developed to analyze and quantify persisting reservoirs of HIV-1-infected cells. SUMMARY: Recent technological advances allow to profile the molecular structure and composition of viral reservoir cells in great detail. Continuous progress in understanding phenotypic and functional properties of viral reservoir cells provides clues for novel clinical interventions to destabilize viral persistence during antiretroviral therapy.
PURPOSE OF REVIEW: Reservoirs of HIV-1-infected cells persist long-term despite highly effective antiretroviral suppression therapy and represent the main barrier against a cure for HIV-1. This review summarizes recent advances in understanding the complexity and diversity of viral reservoir cells. RECENT FINDINGS:Latently infected memoryCD4 T cells are the predominant cell compartment responsible for viral persistence, but some studies suggest that myeloid cells, and possibly hematopoietic progenitors, can also serve as long-term viral reservoirs. Specific phenotypic markers, including T-cell activation and exhaustion molecules, may denote CD4 T cells enriched for replication-competent proviruses. Clonal proliferation of infected CD4 T cells in vivo represents an important mechanism responsible for the remarkable long-term stability of the viral reservoir. Multiple new assays, including near full-genome proviral sequencing and simplified versions of viral outgrowth assays, are being developed to analyze and quantify persisting reservoirs of HIV-1-infected cells. SUMMARY: Recent technological advances allow to profile the molecular structure and composition of viral reservoir cells in great detail. Continuous progress in understanding phenotypic and functional properties of viral reservoir cells provides clues for novel clinical interventions to destabilize viral persistence during antiretroviral therapy.
Authors: Guoxin Wu; Michael Swanson; Aarthi Talla; Donald Graham; Julie Strizki; Daniel Gorman; Richard Jo Barnard; Wade Blair; Ole S Søgaard; Martin Tolstrup; Lars Østergaard; Thomas A Rasmussen; Rafick-Pierre Sekaly; Nancie M Archin; David M Margolis; Daria J Hazuda; Bonnie J Howell Journal: JCI Insight Date: 2017-08-17
Authors: Gábor Artúr Dunay; Anastasia Solomatina; Silke Kummer; Anja Hüfner; Julia Katharina Bialek; Johanna Maria Eberhard; Eva Tolosa; Joachim Hauber; Julian Schulze Zur Wiesch Journal: Virus Res Date: 2017-07-16 Impact factor: 3.303
Authors: Hiroshi Takata; Supranee Buranapraditkun; Cari Kessing; James L K Fletcher; Roshell Muir; Virginie Tardif; Pearline Cartwright; Claire Vandergeeten; Wendy Bakeman; Carmen N Nichols; Suteeraporn Pinyakorn; Pokrath Hansasuta; Eugene Kroon; Thep Chalermchai; Robert O'Connell; Jerome Kim; Nittaya Phanuphak; Merlin L Robb; Nelson L Michael; Nicolas Chomont; Elias K Haddad; Jintanat Ananworanich; Lydie Trautmann Journal: Sci Transl Med Date: 2017-02-15 Impact factor: 17.956
Authors: Emily K Cartwright; Lori Spicer; S Abigail Smith; David Lee; Randy Fast; Sara Paganini; Benton O Lawson; Melon Nega; Kirk Easley; Joern E Schmitz; Steven E Bosinger; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Jacob D Estes; Jeffrey D Lifson; Cynthia A Derdeyn; Guido Silvestri Journal: Immunity Date: 2016-09-20 Impact factor: 31.745
Authors: Line Vibholm; Mariane H Schleimann; Jesper F Højen; Thomas Benfield; Rasmus Offersen; Katrine Rasmussen; Rikke Olesen; Anders Dige; Jørgen Agnholt; Judith Grau; Maria Buzon; Burghardt Wittig; Mathias Lichterfeld; Andreas Munk Petersen; Xutao Deng; Mohamed Abdel-Mohsen; Satish K Pillai; Sofie Rutsaert; Wim Trypsteen; Ward De Spiegelaere; Linos Vandekerchove; Lars Østergaard; Thomas A Rasmussen; Paul W Denton; Martin Tolstrup; Ole S Søgaard Journal: Clin Infect Dis Date: 2017-06-15 Impact factor: 9.079
Authors: Jenna B Honeycutt; William O Thayer; Caroline E Baker; Ruy M Ribeiro; Steven M Lada; Youfang Cao; Rachel A Cleary; Michael G Hudgens; Douglas D Richman; J Victor Garcia Journal: Nat Med Date: 2017-04-17 Impact factor: 53.440
Authors: Ya-Chi Ho; Liang Shan; Nina N Hosmane; Jeffrey Wang; Sarah B Laskey; Daniel I S Rosenbloom; Jun Lai; Joel N Blankson; Janet D Siliciano; Robert F Siliciano Journal: Cell Date: 2013-10-24 Impact factor: 41.582
Authors: Matthieu Perreau; Anne-Laure Savoye; Elisa De Crignis; Jean-Marc Corpataux; Rafael Cubas; Elias K Haddad; Laurence De Leval; Cecilia Graziosi; Giuseppe Pantaleo Journal: J Exp Med Date: 2012-12-17 Impact factor: 14.307
Authors: Aaron S Devanathan; John K Fallon; Nicole R White; Amanda P Schauer; Brian Van Horne; Kimberly Blake; Craig Sykes; Martina Kovarova; Lourdes Adamson; Leila Remling-Mulder; Paul Luciw; J Victor Garcia; Ramesh Akkina; Jason R Pirone; Philip C Smith; Angela D M Kashuba Journal: Antimicrob Agents Chemother Date: 2020-09-21 Impact factor: 5.191
Authors: Geoffrey T Ivison; Elena Vendrame; Giovanny J Martínez-Colón; Thanmayi Ranganath; Rosemary Vergara; Nancy Q Zhao; Maureen P Martin; Sean C Bendall; Mary Carrington; Joshua C Cyktor; Deborah K McMahon; Joseph Eron; R Brad Jones; John W Mellors; Ronald J Bosch; Rajesh T Gandhi; Susan Holmes; Catherine A Blish Journal: Front Cell Infect Microbiol Date: 2022-02-10 Impact factor: 6.073
Authors: Terrin L Manes; Ari Simenauer; Jason L Geohring; Juliana Flemming; Michael Brehm; Adela Cota-Gomez Journal: Free Radic Biol Med Date: 2019-12-19 Impact factor: 7.376
Authors: Christopher C Nixon; Maud Mavigner; Gavin C Sampey; Alyssa D Brooks; Rae Ann Spagnuolo; David M Irlbeck; Cameron Mattingly; Phong T Ho; Nils Schoof; Corinne G Cammon; Greg K Tharp; Matthew Kanke; Zhang Wang; Rachel A Cleary; Amit A Upadhyay; Chandrav De; Saintedym R Wills; Shane D Falcinelli; Cristin Galardi; Hasse Walum; Nathaniel J Schramm; Jennifer Deutsch; Jeffrey D Lifson; Christine M Fennessey; Brandon F Keele; Sherrie Jean; Sean Maguire; Baolin Liao; Edward P Browne; Robert G Ferris; Jessica H Brehm; David Favre; Thomas H Vanderford; Steven E Bosinger; Corbin D Jones; Jean-Pierre Routy; Nancie M Archin; David M Margolis; Angela Wahl; Richard M Dunham; Guido Silvestri; Ann Chahroudi; J Victor Garcia Journal: Nature Date: 2020-01-22 Impact factor: 49.962